These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 15249625)

  • 21. Two Japanese Patients With SMA Type 1 Suggest that Axonal-SMN May Not Modify the Disease Severity.
    Yamada H; Nishida Y; Maihara T; Sa'adah N; Harahap NI; Nurputra DK; Ar Rochmah M; Nishimura N; Saito T; Kubo Y; Saito K; Nishio H
    Pediatr Neurol; 2015 Jun; 52(6):638-41. PubMed ID: 25838041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel 2,4-diaminoquinazoline derivatives as SMN2 promoter activators for the potential treatment of spinal muscular atrophy.
    Thurmond J; Butchbach ME; Palomo M; Pease B; Rao M; Bedell L; Keyvan M; Pai G; Mishra R; Haraldsson M; Andresson T; Bragason G; Thosteinsdottir M; Bjornsson JM; Coovert DD; Burghes AH; Gurney ME; Singh J
    J Med Chem; 2008 Feb; 51(3):449-69. PubMed ID: 18205293
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Classical infantile spinal muscular atrophy with SMN deficiency causes sensory neuronopathy.
    Rudnik-Schöneborn S; Goebel HH; Schlote W; Molaian S; Omran H; Ketelsen U; Korinthenberg R; Wenzel D; Lauffer H; Kreiss-Nachtsheim M; Wirth B; Zerres K
    Neurology; 2003 Mar; 60(6):983-7. PubMed ID: 12654964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intragenic telSMN mutations: frequency, distribution, evidence of a founder effect, and modification of the spinal muscular atrophy phenotype by cenSMN copy number.
    Parsons DW; McAndrew PE; Iannaccone ST; Mendell JR; Burghes AH; Prior TW
    Am J Hum Genet; 1998 Dec; 63(6):1712-23. PubMed ID: 9837824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A genetic and phenotypic analysis in Spanish spinal muscular atrophy patients with c.399_402del AGAG, the most frequently found subtle mutation in the SMN1 gene.
    Cuscó I; López E; Soler-Botija C; Jesús Barceló M; Baiget M; Tizzano EF
    Hum Mutat; 2003 Aug; 22(2):136-43. PubMed ID: 12872254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual Mechanism of a New SMN1 Variant (c.835G>C, p.Gly279Arg) by Interrupting Exon 7 Skipping and YG Oligomerization in Causation of Spinal Muscular Atrophy.
    Bai J; Qu Y; Song F; Cao Y; Cheng M; Wang J; Jin Y; Wang H
    J Mol Neurosci; 2021 Jan; 71(1):112-121. PubMed ID: 32812185
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA).
    Wirth B
    Hum Mutat; 2000; 15(3):228-37. PubMed ID: 10679938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy.
    Al-Jumah M; Majumdar R; Al-Rajeh S; Awada A; Chaves-Carbello E; Salih M; Al-Shahwan S; Al-Subiey K; Al-Uthaim S
    Saudi Med J; 2003 Oct; 24(10):1052-4. PubMed ID: 14578966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Mutation analysis of SMN gene in a patient and his family with spinal muscular atrophy].
    Zeng J; Lin YH; Yan AZ; Cai MY; Ke LF; Lan FH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):139-43. PubMed ID: 19350502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Mutation analysis of SMN1 gene in patients with spinal muscular atrophy].
    DU J; Qu YJ; Xiong H; Li EZ; Jin YW; Bai JL; Wang H; Song F
    Zhonghua Er Ke Za Zhi; 2011 Jun; 49(6):411-5. PubMed ID: 21924051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a novel missense mutation of the SMN(T) gene in two siblings with spinal muscular atrophy.
    Wang CH; Papendick BD; Bruinsma P; Day JK
    Neurogenetics; 1998 Aug; 1(4):273-6. PubMed ID: 10732802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic testing and risk assessment for spinal muscular atrophy (SMA).
    Ogino S; Wilson RB
    Hum Genet; 2002 Dec; 111(6):477-500. PubMed ID: 12436240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis of spinal muscular atrophy in an SMN non-deletion patient using a quantitative PCR screen and mutation analysis.
    Parsons DW; McAndrew PE; Allinson PS; Parker WD; Burghes AH; Prior TW
    J Med Genet; 1998 Aug; 35(8):674-6. PubMed ID: 9719377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular analysis of spinal muscular atrophy and modification of the phenotype by SMN2.
    Mailman MD; Heinz JW; Papp AC; Snyder PJ; Sedra MS; Wirth B; Burghes AH; Prior TW
    Genet Med; 2002; 4(1):20-6. PubMed ID: 11839954
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of a rapid non-invasive technique in the molecular diagnosis of spinal muscular atrophy (SMA).
    Jedrzejowska M; Wiszniewski W; Zimowski J; Kostera-Pruszczyk A; Ryniewicz B; Bal J; Zaremba J; Mazurczak T; Hausmanowa-Petrusewicz I
    Neurol Neurochir Pol; 2005; 39(2):89-94. PubMed ID: 15871052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A non-sequence-specific requirement for SMN protein activity: the role of aminoglycosides in inducing elevated SMN protein levels.
    Wolstencroft EC; Mattis V; Bajer AA; Young PJ; Lorson CL
    Hum Mol Genet; 2005 May; 14(9):1199-210. PubMed ID: 15790598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aclarubicin treatment restores SMN levels to cells derived from type I spinal muscular atrophy patients.
    Andreassi C; Jarecki J; Zhou J; Coovert DD; Monani UR; Chen X; Whitney M; Pollok B; Zhang M; Androphy E; Burghes AH
    Hum Mol Genet; 2001 Nov; 10(24):2841-9. PubMed ID: 11734549
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duplex PCR for preimplantation genetic diagnosis (PGD) of spinal muscular atrophy.
    Moutou C; Gardes N; Viville S
    Prenat Diagn; 2003 Aug; 23(8):685-9. PubMed ID: 12913876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KH-type splicing regulatory protein interacts with survival motor neuron protein and is misregulated in spinal muscular atrophy.
    Tadesse H; Deschênes-Furry J; Boisvenue S; Côté J
    Hum Mol Genet; 2008 Feb; 17(4):506-24. PubMed ID: 17998247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Ewing's sarcoma protein interacts with the Tudor domain of the survival motor neuron protein.
    Young PJ; Francis JW; Lince D; Coon K; Androphy EJ; Lorson CL
    Brain Res Mol Brain Res; 2003 Nov; 119(1):37-49. PubMed ID: 14597228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.